AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Clinical trial NCT07617337 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07617337
- Sponsor
- Chugai Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2030-08-31
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.